• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    J&J’s Single-Dose COVID-19 Vax Issued EUA

    Icon to Acquire PRA Health Sciences

    Phlow Corp. and USP Form Alliance

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology

    Solid Dose Market Trends

    CatSci Opens New Site in UK
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Icon to Acquire PRA Health Sciences

    BMS Expands Cell Therapy Manufacturing Capabilities

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Reed-Lane

    Flow Sciences

    Aphena Pharma Solutions

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Syngene

    Adare Pharma Solutions

    Emergent BioSolutions

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    India Report

    The Similar Mantra

    Early birds bet big on biosimilars.

    The Similar Mantra
    S. Harachand, Contributing Editor01.28.20
    Biosimilars bring in some great tidings for the new year and perhaps for the new decade. The Indian pharma industry is abuzz with biosimilar stories. So far, Indian companies have launched 123 biosimilars and currently have a development pipeline comprising 201 molecules, according to a new report released by Clarivate Analytics.

    Presently, one in every three new drugs approved is a biotech drug. Of the top 10 blockbusters in 2018, only two were small molecule therapeutics and eight were biologicals. No wonder, if the cost-effective versions of innovator biologics have become the new mantra for an industry that has already earned a repute producing cheaper copies for almost every small molecule pharmaceutical product.

    Companies from India have made some big forays into the biosimilars space, despite the complexity and heightened costs associated with these living-cell derived products.

    They are among the foremost entrants in the global biosimilars business. Biocon Biologics, a subsidiary of Biocon, has got biosimilar products approved in various developed markets including the U.S., the EU, Japan and Australia.

    Unsurprisingly, the biggest headline on this front comes from this biotherapeutics major itself. In early January, Biocon said that True North, a private equity firm, would buy a 2.5% stake in Biocon Biologics for a sum of $75 million.

    The announcement came close on the heels of Biocon’s successful commercialization of the company’s second biosimilar, trastuzumab-dkst (Ogivri), in the U.S. market. Co-developed by Mylan, Ogivri was the first biosimilar trastuzumab approved by the U.S. FDA and unanimously recommended by the FDA Oncologic Drugs Advisory Committee (ODAC), Biocon said. The companies launched biosimilar pegfilgrastim in 2018.

    Biocon and Mylan are exclusive partners on a broad portfolio of biosimilars and insulin analogs. The fresh investment from True North will boost Biocon Biologic’s market value to around $3 billion.

    According to the company, this investment is an endorsement of the value that Biocon has demonstrated as a global biosimilars player. Apart from the U.S., Biocon has commercialized its trastuzumab biosimilar in over 80 markets worldwide.

    Biocon plans to broaden its pipeline and expand manufacturing capacities to increase the company’s commercial footprint.

    Currently, the company claims to have one of the largest global biosimilar portfolios with products across therapeutic categories such as oncology, immunology, rheumatology and diabetology. The product basket includes the molecules being developed in association with Mylan and Sandoz.

    Biocon and Sandoz, the generics arm of Novartis, reached a pact to jointly invest and co-develop, manufacture and market, a new range of biosimilars in immunology and cancer for the global markets in 2018.

    Last October Biocon Biologics signed a licensing agreement with Just-Evotec Biologics, wholly owned by the Hamburg head-quartered Evotec, for an early stage, preclinical biosimilar.

    Biocon has built huge state-of-the-art biomanufacturing facilities for insulins and monoclonal antibodies in India and Malaysia.

    The company targets a revenue milestone of $1 billion by FY22 from biosimilars business.

    The global biosimilars market is expected to grow to $23.6 billion by 2023, from $5.9 billion in the calendar year 2018, backed by several biologicals losing patent protection globally, says a report by Icra Research, a credit rating agency.

    The global market is on the cusp of exceptional growth and presents attractive opportunities for pharmaceutical companies in the years to come.

    Select Indian pharma companies with strong R&D capabilities will be in a position to exploit these opportunities in the key markets of the U.S., Europe and the rest of the world, the report adds.

    Almost all leading companies in India have bio drug portfolios. Foreseeing the unfolding opportunity, some early movers have made significant investments into developing biosimilar products.

    Intas Pharmaceuticals, for instance, was the first Indian company to get a biosimilar (filgrastim) launched in the EU in 2015. The Ahmedabad-based biotech firm, which commercialized pegylated G-CSF biosimilar in Europe 2018, has lined up three more in the pipeline for Europe. The company is also hopeful of getting its first biosimilar approved in the U.S. this year.

    Meanwhile, Lupin Ltd., a comparatively late entrant in the field, has slated several biosimilars for launch in the EU and other markets eyeing a 10% market share over the next five years.

    Dr. Reddy’s Laboratories, Zydus Cadila, Reliance Life Sciences, Aurobindo, Glenmark, Emcure, and Alkem Labs are among the leading players in the growing list of companies aggressively pursuing biosimilars.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • novartis
    • analytics
    • monoclonal antibodies
    • fda

    Related India Report

    • Biosimilars | Risk Management

      India Revises Biosimilars Guidelines

      Stricter quality, safety norms on cards
      S. Harachand, Contributing Editor 05.05.16

    • Biosimilars | Clinical Trials

      Indian Generics Expand in mAbs

      As they focus on generic biologics, Indian firms are setting their sights on monoclonal antibodies
      S. Harachand, Contributing Editor 07.21.14

    • Biosimilars | Chemistry | Drug Discovery

      Speeding Discovery

      ...
      S. Harachand, Contributing Editor 03.07.14


    • APIs | Aseptic Processing | Biosimilars | Injectables | Lyophilization | Parenterals | Supply Chain | Vials

      Unlocking the Value of Injectables

      Injectables CMOs steal the show
      S. Harachand, Contributing Editor 11.13.13

    • Biosimilars | Drug Discovery

      (Bio)Similar Deals

      New models emerge in biogenerics sourcing
      S. Harachand, Contributing Editor 07.18.12

    • Biologics, Proteins, Vaccines | Biosimilars | R&D

      Move To Monoclonals

      CMOs' MAb skills in the spotlight
      S Harachand 04.04.12


    • Biosimilars

      Biotech Rebounds

      Generics, vaccines fuel growth
      S. Harachand, Contributing Editor 06.06.11

    • Bioassay Development | Biologics, Proteins, Vaccines | Biosimilars | Clinical Trials | Drug Development | Methods Development | Process Development | R&D | Toxicology

      Eyeing A 'Similar' Pie

      Is a bet on cheaper bio-drugs safe?
      S. Harachand 04.29.11

    • Biosimilars | Clinical Trials | R&D

      Vaccine Players on The Move

      Great potential for vaccine services
      S. Harachand 06.01.10


    • Biosimilars

      The Emerging Second Wave

      High-quality, low-cost bio-CMOs rally forth
      S. Harachand 10.08.09

    Trending
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    • The Future Of Vaccines And Biologics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • J&J’s Single-Dose COVID-19 Vax Issued EUA
    • Icon to Acquire PRA Health Sciences
    • Phlow Corp. and USP Form Alliance
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Novo Nordisk Invests $80M in Tablet Production
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Mule-Hide Products Co. Promotes Steven Litaker to Territory Manager
    Terra Firma, Wanhua Announce New Distribution Partnership
    Gelest CEO Elected to National Academy of Engineering
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login